Literature DB >> 10390224

Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.

J J Hilliard1, R M Goldschmidt, L Licata, E Z Baum, K Bush.   

Abstract

Many pathogenic bacteria utilize two-component systems consisting of a histidine protein kinase (HPK) and a response regulator (RR) for signal transduction. During the search for novel inhibitors, several chemical series, including benzoxazines, benzimidazoles, bis-phenols, cyclohexenes, trityls, and salicylanilides, were identified that inhibited the purified HPK-RR pairs KinA-Spo0F and NRII-NRI, with 50% inhibitory concentrations (IC50s) ranging from 1.9 to >500 microM and MICs ranging from 0.5 to >16 microg/ml for gram-positive bacteria. However, additional observations suggested that mechanisms other than HPK inhibition might contribute to antibacterial activity. In the present work, representative compounds from the six different series of inhibitors were analyzed for their effects on membrane integrity and macromolecular synthesis. At 4x MIC, 17 of 24 compounds compromised the integrity of the bacterial cell membrane within 10 min, as measured by uptake of propidium iodide. In this set, compounds with lower IC50s tended to cause greater membrane disruption. Eleven of 12 compounds inhibited cellular incorporation of radiolabeled thymidine and uridine >97% in 5 min and amino acids >80% in 15 min. The HPK inhibitor that allowed >25% precursor incorporation had no measurable MIC (>16 microg/ml). Fifteen of 24 compounds also caused hemolysis of equine erythrocytes. Thus, the antibacterial HPK inhibitors caused a rapid decrease in cellular incorporation of RNA, DNA, and protein precursors, possibly as a result of the concomitant disruption of the cytoplasmic membrane. Bacterial killing by these HPK inhibitors may therefore be due to multiple mechanisms, independent of HPK inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390224      PMCID: PMC89345     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Compilation of all genes encoding two-component phosphotransfer signal transducers in the genome of Escherichia coli.

Authors:  T Mizuno
Journal:  DNA Res       Date:  1997-04-28       Impact factor: 4.458

Review 2.  The two-component system. Regulation of diverse signaling pathways in prokaryotes and eukaryotes.

Authors:  C Chang; R C Stewart
Journal:  Plant Physiol       Date:  1998-07       Impact factor: 8.340

3.  Structure of the CheY-binding domain of histidine kinase CheA in complex with CheY.

Authors:  M Welch; N Chinardet; L Mourey; C Birck; J P Samama
Journal:  Nat Struct Biol       Date:  1998-01

4.  Antibacterial agents that inhibit two-component signal transduction systems.

Authors:  J F Barrett; R M Goldschmidt; L E Lawrence; B Foleno; R Chen; J P Demers; S Johnson; R Kanojia; J Fernandez; J Bernstein; L Licata; A Donetz; S Huang; D J Hlasta; M J Macielag; K Ohemeng; R Frechette; M B Frosco; D H Klaubert; J M Whiteley; L Wang; J A Hoch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Molecular recognition in signal transduction: the interaction surfaces of the Spo0F response regulator with its cognate phosphorelay proteins revealed by alanine scanning mutagenesis.

Authors:  Y L Tzeng; J A Hoch
Journal:  J Mol Biol       Date:  1997-09-19       Impact factor: 5.469

6.  Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin.

Authors:  K C Quon; B Yang; I J Domian; L Shapiro; G T Marczynski
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

7.  Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei.

Authors:  A L Jones; D DeShazer; D E Woods
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

8.  Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.

Authors:  M J Macielag; J P Demers; S A Fraga-Spano; D J Hlasta; S G Johnson; R M Kanojia; R K Russell; Z Sui; M A Weidner-Wells; H Werblood; B D Foleno; R M Goldschmidt; M J Loeloff; G C Webb; J F Barrett
Journal:  J Med Chem       Date:  1998-07-30       Impact factor: 7.446

9.  Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.

Authors:  D J Hlasta; J P Demers; B D Foleno; S A Fraga-Spano; J Guan; J J Hilliard; M J Macielag; K A Ohemeng; C M Sheppard; Z Sui; G C Webb; M A Weidner-Wells; H Werblood; J F Barrett
Journal:  Bioorg Med Chem Lett       Date:  1998-07-21       Impact factor: 2.823

10.  A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence.

Authors:  H Jungnitz; N P West; M J Walker; G S Chhatwal; C A Guzmán
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more
  52 in total

1.  Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.

Authors:  L E Alksne; P Burgio; W Hu; B Feld; M P Singh; M Tuckman; P J Petersen; P Labthavikul; M McGlynn; L Barbieri; L McDonald; P Bradford; R G Dushin; D Rothstein; S J Projan
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent.

Authors:  Clare E Blue; Tim J Mitchell
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.

Authors:  Yu-Hsuan Ho; Tzu-Cheng Sung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-02       Impact factor: 5.911

4.  In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.

Authors:  Ed T Buurman; Beth Andrews; Ning Gao; Jun Hu; Thomas A Keating; Sushmita Lahiri; Ludovic R Otterbein; Arthur D Patten; Suzanne S Stokes; Adam B Shapiro
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

5.  Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

Authors:  Trudy H Grossman; Douglas J Bartels; Steve Mullin; Christian H Gross; Jonathan D Parsons; Yusheng Liao; Anne-Laure Grillot; Dean Stamos; Eric R Olson; Paul S Charifson; Nagraj Mani
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 6.  Mode of action of microbial bioactive metabolites.

Authors:  V Bethal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

7.  The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.

Authors:  Thibaut Boibessot; Christopher P Zschiedrich; Alexandre Lebeau; David Bénimèlis; Catherine Dunyach-Rémy; Jean-Philippe Lavigne; Hendrik Szurmant; Zohra Benfodda; Patrick Meffre
Journal:  J Med Chem       Date:  2016-09-26       Impact factor: 7.446

8.  Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.

Authors:  Vandana Kalia; Rajni Miglani; Kedar P Purnapatre; Tarun Mathur; Smita Singhal; Seema Khan; Sreedhara R Voleti; Dilip J Upadhyay; Kulvinder Singh Saini; Ashok Rattan; V Samuel Raj
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.

Authors:  E Z Baum; D A Montenegro; L Licata; I Turchi; G C Webb; B D Foleno; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.

Authors:  Ayome Abibi; Andrew D Ferguson; Paul R Fleming; Ning Gao; Laurel I Hajec; Jun Hu; Valerie A Laganas; David C McKinney; Sarah M McLeod; D Bryan Prince; Adam B Shapiro; Ed T Buurman
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.